(+/-)-Tulipaline B

(+/-)-Tulipaline B

SCHEMBL4922801

C=C1C(=O)OC[C@H]1O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+/-)-Tulipaline B SCHEMBL4926880 1.00
(+/-)-Tulipaline B SCHEMBL1073177 1.00
SCHEMBL3944987 0.70
SCHEMBL3947301 0.70
SCHEMBL1801718 0.70
SCHEMBL2376391 0.70
SCHEMBL8398217 0.70 KDM1A (0.35)
SCHEMBL16431282 0.70
SCHEMBL3196631 0.70 ATM (0.39)
SCHEMBL4162224 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250093345-A1 Optical biomodule for detection of diseases at an early onset MAZED MOHAMMAD A (US) 2025-03-20 US disclosed
US-12135286-B1 Optical biomodule for detection of diseases at an early onset MAZED MOHAMMAD A (US) 2024-11-05 US disclosed
US-12123041-B2 Method for the production of amino sugar-containing products UNIVERSITEIT GENT (BE) 2024-10-22 US disclosed
US-11747279-B2 Optical biomodule for detection of diseases at an early onset MAZED MOHAMMAD A (US) 2023-09-05 US disclosed
US-20080262082-A1 COMPOSITION CONTAINING S-(-)-TULIPALIN B OR ACETYLATED-S-(-)-TULIPALIN B BIO SPECTRUM, INC. (KR) 2008-10-23 US disclosed